Literature DB >> 12676184

Laboratory diagnosis of the antiphospholipid syndrome.

Finn Wisløff1, Eva M Jacobsen, Sigurd Liestøl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12676184     DOI： 10.1016/s0049-3848(02)00400-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  17 in total

1.  Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.

Authors:  Simone Appenzeller; Steeven Yeh; Marcelo Maruyama; Solange Murta Barros; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

2.  Lack of antiphospolipid antibodies in long-term cardiac rheumatic fever.

Authors:  Jozélio Freire de Carvalho; Cláudia Goldenstein-Schainberg
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

Review 3.  [Antiphospholipid syndrome 2007. Current aspects of laboratory diagnostics and their therapeutic consequences].

Authors:  S Schuchmann; T Dörner
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

4.  Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?

Authors:  Elisa Watanabe Camargo; Paula Vieira Freire; Clovis Artur Silva; Nelita Rocha dos Santos; Licia Maria Henrique da Mota; Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

5.  Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome.

Authors:  Sandra Gofinet Pasoto; Henrique Pires Chakkour; Renato Romera Natalino; Vilma S T Viana; Cleonice Bueno; Alessandro Cavalcanti Lianza; José Lázaro de Andrade; Mauricio Levy Neto; Ricardo Fuller; Eloisa Bonfa
Journal:  Clin Rheumatol       Date:  2012-06-13       Impact factor: 2.980

6.  [Antiphospholipid syndrome].

Authors:  C Specker
Journal:  Z Rheumatol       Date:  2007-02       Impact factor: 1.372

7.  Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.

Authors:  Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Adriano Alatri; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Journal:  J Thromb Thrombolysis       Date:  2009-03-14       Impact factor: 2.300

8.  Penile alterations with severe sperm abnormalities in antiphospholipid syndrome associated with systemic lupus erythematosus.

Authors:  Carlos Nobre Rabelo-Júnior; Eloisa Bonfá; Jozélio F Carvalho; Marcello Cocuzza; Osmar Saito; Carmita H Abdo; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2012-09-11       Impact factor: 2.980

9.  Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?

Authors:  Paula Vieira Freire; Elisa Watanabe; Nelita Rocha dos Santos; Cleonice Bueno; Eloísa Bonfá; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2014-01-14       Impact factor: 2.980

10.  Antiphospholipid-related chorea.

Authors:  Silvio Peluso; Antonella Antenora; Anna De Rosa; Alessandro Roca; Gennaro Maddaluno; Vincenzo Brescia Morra; Giuseppe De Michele
Journal:  Front Neurol       Date:  2012-10-22       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.